The Recall Desk
CriticalFDA (Drugs)·D-1231-2014·Announced 2014-04-23

Slim Fortune capsules recalled for undeclared sibutramine

B @ B Trade Inc. is recalling Slim Fortune capsules because they contain undeclared sibutramine and were marketed without FDA approval.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 per the rubric.

Plain-English summary

B @ B Trade Inc. is recalling Slim Fortune capsules, a dietary supplement sold in bottles of 30 capsules. The recall covers 10 bottles distributed nationwide across all lots.

The FDA is recalling the product because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) and was found to contain undeclared sibutramine. Sibutramine is a prescription drug that was withdrawn from the US market due to safety concerns.

Consumers who have purchased Slim Fortune capsules should stop using the product immediately. The source text does not provide specific instructions for disposal or return, but consumers should generally follow FDA guidance for handling recalled supplements.

The recalled product

Product
Slim Fortune capsules Dietary Supplement. Each bottle contains 30 capsules.
Manufacturer
B @ B Trade Inc.
Affected units
10

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • ALL LOTS

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 3 recalled by B @ B Trade Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →

Same manufacturer · B @ B Trade Inc.

See all →